» Articles » PMID: 35370984

Association Between METS-IR and Prehypertension or Hypertension Among Normoglycemia Subjects in Japan: A Retrospective Study

Overview
Specialty Endocrinology
Date 2022 Apr 4
PMID 35370984
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Our study aimed to investigate the association between the novel non-insulin-based metabolic score for insulin resistance (METS-IR) index and pre-hypertension (HTN) or HTN in normoglycemia Japanese participants.

Methods: The NAGALA medical examination program at Murakami Memorial Hospital in Gifu, Japan was found in 1994. 15,453 participants enrolled in this program from 2004 to 2015 was included in this retrospective study to explore the association between the METS-IR index and pre-HTN or HTN. Covariates included serum biomarkers and clinicodemographic characteristics. Logistic regression was applied to explore the association between METS-IR level and pre-HTN or HTN.

Results: This study includes a total of 15453 participants. The prevalence rates of pre-HTN and HTN were 28.55% (4412/15453) and 6.23% (962/15453), respectively. Adjusted for confounding factors in the multivariable logistic regression analysis models, when METS-IR was used as a categorical variable, high METS-IR was significantly associated with both pre-HTN (adjusted odds ratio (OR) = 1.95, 95% confidence interval (CI): 1.61-2.36) and HTN (adjusted OR = 2.12, 95% CI: 1.44-3.11). When METS-IR was used as a continuous variable, each 1 unit increase in METS-IR was associated with a 7% increase in the prevalence of pre-HTN (adjusted OR = 1.07, 95% CI: 1.06-1.08) and with a 13% increase in the prevalence of HTN (adjusted OR = 1.13, 95% CI: 1.10-1.16). Stratified analyses indicated a positive correlation between METS-IR and pre-HTN or HTN in normoglycemia subjects with different characteristics.

Conclusions: METS-IR levels are significantly associated with pre-HTN or HTN in normoglycemia individuals in Gifu, Japan. METS-IR may be used as a monitoring indicator for the development of HTN primary prevention and management strategies in the future, but it still needs more research to confirm.

Citing Articles

The Association of the Metabolic Score for Insulin Resistance (METS-IR) with Prehypertension in Normoglycemic Individuals.

Alogaili M, Alsallami A Int J Endocrinol Metab. 2025; 22(2):e145894.

PMID: 40071249 PMC: 11892513. DOI: 10.5812/ijem-145894.


Association of metabolic score for insulin resistance with incident metabolic syndrome: a cohort study in middle-aged and older adult Chinese population.

Zhang Q, Wei Y, Huang S, Mo Y, Yan B, Jin X Front Public Health. 2025; 13:1453144.

PMID: 40051521 PMC: 11883690. DOI: 10.3389/fpubh.2025.1453144.


Relationship of METS-IR with cardiometabolic multimorbidity in China: a nationwide longitudinal cohort study.

Zhou C, Zhang Y, Liu X, He C, Li S Front Nutr. 2025; 12:1518840.

PMID: 40013162 PMC: 11860098. DOI: 10.3389/fnut.2025.1518840.


Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007-2018.

Guo Z, Guo X, Xu H, Chu H, Tian Y, Wang S Lipids Health Dis. 2025; 24(1):64.

PMID: 39985010 PMC: 11843973. DOI: 10.1186/s12944-025-02492-y.


Associations between non-insulin-based insulin resistance indices and diabetic nephropathy in patients with diabetes mellitus in US adults: a cross-sectional study of NHANES 1999-2018.

Zhang F, Han Y, Mao Y, Li W Front Endocrinol (Lausanne). 2024; 15:1458521.

PMID: 39720248 PMC: 11666371. DOI: 10.3389/fendo.2024.1458521.


References
1.
Bello-Chavolla O, Antonio-Villa N, Vargas-Vazquez A, Martagon A, Mehta R, Arellano-Campos O . Prediction of incident hypertension and arterial stiffness using the non-insulin-based metabolic score for insulin resistance (METS-IR) index. J Clin Hypertens (Greenwich). 2019; 21(8):1063-1070. PMC: 8030285. DOI: 10.1111/jch.13614. View

2.
Kim J, Montagnani M, Kon Koh K, Quon M . Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006; 113(15):1888-904. DOI: 10.1161/CIRCULATIONAHA.105.563213. View

3.
Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G . Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens. 2001; 14(11 Pt 2):304S-309S. DOI: 10.1016/s0895-7061(01)02236-1. View

4.
Li Y, You A, Tomlinson B, Yue L, Zhao K, Fan H . Insulin resistance surrogates predict hypertension plus hyperuricemia. J Diabetes Investig. 2021; 12(11):2046-2053. PMC: 8565421. DOI: 10.1111/jdi.13573. View

5.
Jia G, Demarco V, Sowers J . Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2015; 12(3):144-53. PMC: 4753054. DOI: 10.1038/nrendo.2015.216. View